Literature DB >> 34129451

"It's Really Like Any Other Study": Rural Radiology Facilities Performing Low-Dose Computed Tomography for Lung Cancer Screening.

Christopher G Slatore1,2,3,4, Sara E Golden1, Tara Thomas1, Sarah Bumatay5, Jackilen Shannon6,7, Melinda Davis5,8,7.   

Abstract

Rationale: The majority of eligible people have not been screened for lung cancer. There is emerging evidence that there are location-based disparities applicable to lung cancer screening (LCS).
Objectives: To describe LCS radiologic services in rural Oregon and understand the barriers and facilitators to implementation of LCS using low-dose computed tomography (LDCT).
Methods: This was a mixed-method descriptive study using surveys and semistructured interviews of key informants. We approached representatives from all 37 small and rural hospitals in Oregon. We purposively interviewed key informants from a subset based on LDCT implementation outcomes.
Results: We surveyed representatives from 29 radiology facilities and qualitatively interviewed 18 key informants from 19 facilities (representing 12 healthcare systems). Among the surveyed radiology facilities, 59% were performing LDCT for LCS. Key informants reported that facilities that performed this service were often motivated by community needs and were less motivated by financial gain or evidence strength, and all described the importance of having a champion. Key informants described that LCS programmatic components that were within their normal scope of practice (e.g., specifying the LDCT parameters) were burdensome to establish but that barriers were surmountable. Most informants reported they did not perform other components of high-quality programs (e.g., ensuring adherence to recommended follow-up testing) and suggested that these steps were important but were the responsibility of primary care providers. Conclusions: Many rural hospital facilities in Oregon offer LDCT for LCS but do not perform all the recommended components of a screening program. Disparities in LCS use and adherence are unlikely to be solved by an exclusive focus at the radiology facility level and may require additional interventions at the primary care level.

Entities:  

Keywords:  cancer screening; implementation; radiology; rural hospitals

Mesh:

Year:  2021        PMID: 34129451      PMCID: PMC8641809          DOI: 10.1513/AnnalsATS.202103-333OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  37 in total

1.  The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.

Authors:  Michael T Jaklitsch; Francine L Jacobson; John H M Austin; John K Field; James R Jett; Shaf Keshavjee; Heber MacMahon; James L Mulshine; Reginald F Munden; Ravi Salgia; Gary M Strauss; Scott J Swanson; William D Travis; David J Sugarbaker
Journal:  J Thorac Cardiovasc Surg       Date:  2012-07       Impact factor: 5.209

2.  Three approaches to qualitative content analysis.

Authors:  Hsiu-Fang Hsieh; Sarah E Shannon
Journal:  Qual Health Res       Date:  2005-11

3.  Patient Reminders and Longitudinal Adherence to Lung Cancer Screening in an Academic Setting.

Authors:  Erin A Hirsch; Melissa L New; Stephanie P Brown; Anna E Barón; Stephen P Malkoski
Journal:  Ann Am Thorac Soc       Date:  2019-10

4.  What Exactly Is Shared Decision-Making? A Qualitative Study of Shared Decision-Making in Lung Cancer Screening.

Authors:  Anne C Melzer; Sara E Golden; Sarah S Ono; Santanu Datta; Kristina Crothers; Christopher G Slatore
Journal:  J Gen Intern Med       Date:  2019-11-19       Impact factor: 5.128

5.  Implementation of Lung Cancer Screening in the Veterans Health Administration.

Authors:  Linda S Kinsinger; Charles Anderson; Jane Kim; Martha Larson; Stephanie H Chan; Heather A King; Kathryn L Rice; Christopher G Slatore; Nichole T Tanner; Kathleen Pittman; Robert J Monte; Rebecca B McNeil; Janet M Grubber; Michael J Kelley; Dawn Provenzale; Santanu K Datta; Nina S Sperber; Lottie K Barnes; David H Abbott; Kellie J Sims; Richard L Whitley; R Ryanne Wu; George L Jackson
Journal:  JAMA Intern Med       Date:  2017-03-01       Impact factor: 21.873

6.  Establishing rigour in qualitative research: the decision trail.

Authors:  T Koch
Journal:  J Adv Nurs       Date:  1994-05       Impact factor: 3.187

Review 7.  Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation.

Authors:  Linda L Humphrey; Mark Deffebach; Miranda Pappas; Christina Baumann; Kathryn Artis; Jennifer Priest Mitchell; Bernadette Zakher; Rongwei Fu; Christopher G Slatore
Journal:  Ann Intern Med       Date:  2013-09-17       Impact factor: 25.391

8.  An official American thoracic society workshop report: developing performance measures from clinical practice guidelines.

Authors:  Jeremy M Kahn; Michael K Gould; Jerry A Krishnan; Kevin C Wilson; David H Au; Colin R Cooke; Ivor S Douglas; Laura C Feemster; Richard A Mularski; Christopher G Slatore; Renda Soylemez Wiener
Journal:  Ann Am Thorac Soc       Date:  2014-05

Review 9.  Inside help: An integrative review of champions in healthcare-related implementation.

Authors:  Edward J Miech; Nicholas A Rattray; Mindy E Flanagan; Laura Damschroder; Arlene A Schmid; Teresa M Damush
Journal:  SAGE Open Med       Date:  2018-05-17

10.  How Health-Care Organizations Implement Shared Decision-making When It Is Required for Reimbursement: The Case of Lung Cancer Screening.

Authors:  Amir Alishahi Tabriz; Christine Neslund-Dudas; Kea Turner; M Patricia Rivera; Daniel S Reuland; Jennifer Elston Lafata
Journal:  Chest       Date:  2020-08-13       Impact factor: 9.410

View more
  1 in total

1.  Beliefs and Practices of Primary Care Providers Regarding Performing Low-Dose CT Studies for Lung Cancer Screening.

Authors:  Christopher G Slatore; Sara E Golden; Tara Thomas; Mary Patzel; Sarah Bumatay; Jackilen Shannon; Melinda Davis
Journal:  Chest       Date:  2021-09-01       Impact factor: 9.410

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.